Proteomic analysis of mismatch repair-mediated alkylating agent-induced DNA damage response

Cell & Bioscience
|December 17, 2013
PubMed
Abstract

Insights

The mismatch repair (MMR) system mediates DNA damage-induced apoptosis. MMR deficiency hinders this process, leading to drug resistance and promoting cancer cell proliferation.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The mismatch repair (MMR) system is crucial for genome maintenance, specifically in mediating DNA damage-induced apoptosis.
  • Defects in MMR are linked to carcinogenesis and resistance to chemotherapy, particularly alkylating agents.
  • Understanding MMR's role in apoptosis and drug resistance is vital for cancer treatment strategies.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying MMR-mediated apoptosis.
  • To elucidate how MMR deficiency contributes to resistance against chemotherapeutics.
  • To analyze proteomic changes in response to a model alkylating agent in MMR-proficient and deficient cells.

Main Methods:

  • Utilized two cell lines: MMR-proficient TK6 and MMR-deficient MT1.
  • Administered N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), a model alkylating agent.
  • Performed quantitative proteomic analysis to assess protein expression and phosphorylation changes.

Main Results:

  • MNNG induced apoptosis only in MMR-proficient TK6 cells, not in MMR-deficient MT1 cells.
  • Proteomic analysis revealed differential protein expression and phosphorylation patterns between the two cell lines.
  • TK6 cells showed activation of apoptotic pathways, while MT1 cells exhibited promotion of proliferation and anti-apoptotic responses.

Conclusions:

  • The study provides novel molecular insights into the mechanism of MMR-mediated DNA damage-induced apoptosis.
  • Findings highlight distinct cellular responses to DNA damage based on MMR proficiency.
  • This research deepens our understanding of cancer cell survival mechanisms and potential therapeutic vulnerabilities.